Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Stress Chaperone Mortalin Contributes to Epithelial-to-Mesenchymal Transition and Cancer Metastasis
Youjin Na, Sunil C. Kaul, Jihoon Ryu, et al.
Cancer Research (2016) Vol. 76, Iss. 9, pp. 2754-2765
Open Access | Times Cited: 96

Showing 1-25 of 96 citing articles:

Cancer chemotherapy and beyond: Current status, drug candidates, associated risks and progress in targeted therapeutics
Uttpal Anand, Abhijit Dey, Arvind K. Singh Chandel, et al.
Genes & Diseases (2022) Vol. 10, Iss. 4, pp. 1367-1401
Open Access | Times Cited: 755
Heat Shock Proteins and Cancer
Jianming Wu, Tuoen Liu, Zechary Rios, et al.
Trends in Pharmacological Sciences (2016) Vol. 38, Iss. 3, pp. 226-256
Closed Access | Times Cited: 604
Heat Shock Proteins: Agents of Cancer Development and Therapeutic Targets in Anti-Cancer Therapy
Chul Won Yun, Hyung Joo Kim, Ji Ho Lim, et al.
Cells (2019) Vol. 9, Iss. 1, pp. 60-60
Open Access | Times Cited: 238
The Role of Epithelial-to-Mesenchymal Plasticity in Ovarian Cancer Progression and Therapy Resistance
Nele Loret, Hannelore Denys, Philippe Tummers, et al.
Cancers (2019) Vol. 11, Iss. 6, pp. 838-838
Open Access | Times Cited: 211
The mitochondrial unfolded protein response (UPRmt): shielding against toxicity to mitochondria in cancer
Joseph R. Inigo, Dhyan Chandra
Journal of Hematology & Oncology (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 70
The assembly of succinate dehydrogenase: a key enzyme in bioenergetics
Behrooz Moosavi, Edward A. Berry, Xiao‐Lei Zhu, et al.
Cellular and Molecular Life Sciences (2019) Vol. 76, Iss. 20, pp. 4023-4042
Closed Access | Times Cited: 121
Mitochondrial dysfunction in cancer: Potential roles of ATF5 and the mitochondrial UPR
Pan Deng, Cole M. Haynes
Seminars in Cancer Biology (2017) Vol. 47, pp. 43-49
Open Access | Times Cited: 94
Molecular Chaperones in Cancer Stem Cells: Determinants of Stemness and Potential Targets for Antitumor Therapy
Alexander E. Kabakov, A. O. Yakimova, Olga N. Matchuk
Cells (2020) Vol. 9, Iss. 4, pp. 892-892
Open Access | Times Cited: 92
Aberrant alternative splicing in breast cancer
Quan Yang, Jinyao Zhao, Wenjing Zhang, et al.
Journal of Molecular Cell Biology (2019) Vol. 11, Iss. 10, pp. 920-929
Open Access | Times Cited: 84
Experimental Evidence for Therapeutic Potentials of Propolis
Priyanshu Bhargava, Debajit Mahanta, A. Kaul, et al.
Nutrients (2021) Vol. 13, Iss. 8, pp. 2528-2528
Open Access | Times Cited: 58
HSP70 and HSP90 in Cancer: Cytosolic, Endoplasmic Reticulum and Mitochondrial Chaperones of Tumorigenesis
Zarema Albakova, Yana Mangasarova, Akhmet Albakov, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 48
Therapeutic strategies of dual-target small molecules to overcome drug resistance in cancer therapy
Jing Ye, Junhao Wu, Bo Liu
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2023) Vol. 1878, Iss. 3, pp. 188866-188866
Closed Access | Times Cited: 27
Mitochondrial unfolded protein response (UPRmt): what we know thus far
Angie K. Torres, Veronika Fleischhart, Nibaldo C. Inestrosa
Frontiers in Cell and Developmental Biology (2024) Vol. 12
Open Access | Times Cited: 11
Molecular Characterization and Enhancement of Anticancer Activity of Caffeic Acid Phenethyl Ester by γ Cyclodextrin
Renu Wadhwa, Nupur Nigam, Priyanshu Bhargava, et al.
Journal of Cancer (2016) Vol. 7, Iss. 13, pp. 1755-1771
Open Access | Times Cited: 72
Relevance of mortalin to cancer cell stemness and cancer therapy
Chae‐Ok Yun, Priyanshu Bhargava, Youjin Na, et al.
Scientific Reports (2017) Vol. 7, Iss. 1
Open Access | Times Cited: 63
Towards Resolving the Pro- and Anti-Tumor Effects of the Aryl Hydrocarbon Receptor
Supraja Narasimhan, Elizabeth Zulick, Olga Novikov, et al.
International Journal of Molecular Sciences (2018) Vol. 19, Iss. 5, pp. 1388-1388
Open Access | Times Cited: 60
Pharmacogenomic landscape of head and neck squamous cell carcinoma informs precision oncology therapy
Ziyue Gu, Yanli Yao, Guizhu Yang, et al.
Science Translational Medicine (2022) Vol. 14, Iss. 661
Closed Access | Times Cited: 30
Mortalin: Protein partners, biological impacts, pathological roles, and therapeutic opportunities
Niki Esfahanian, Cole Knoblich, Gaven Bowman, et al.
Frontiers in Cell and Developmental Biology (2023) Vol. 11
Open Access | Times Cited: 19
Targeting GRP75 with a Chlorpromazine Derivative Inhibits Endometrial Cancer Progression Through GRP75–IP3R‐Ca2+‐AMPK Axis
Qi Xia Wang, Lijuan Li, Xiaoyan Gao, et al.
Advanced Science (2024) Vol. 11, Iss. 15
Open Access | Times Cited: 7
Keratin gene signature expression drives epithelial-mesenchymal transition through enhanced TGF-β signaling pathway activation and correlates with adverse prognosis in lung adenocarcinoma
Gang Li, Jinbao Guo, Yun-Fei Mou, et al.
Heliyon (2024) Vol. 10, Iss. 3, pp. e24549-e24549
Open Access | Times Cited: 6
Cancer cell responses to Hsp70 inhibitor JG-98: Comparison with Hsp90 inhibitors and finding synergistic drug combinations
Julia A. Yaglom, Yongmei Wang, Amy Li, et al.
Scientific Reports (2018) Vol. 8, Iss. 1
Open Access | Times Cited: 57
Marine Carotenoid Fucoxanthin Possesses Anti-Metastasis Activity: Molecular Evidence
Sukant Garg, Sajal Afzal, Ahmed Elwakeel, et al.
Marine Drugs (2019) Vol. 17, Iss. 6, pp. 338-338
Open Access | Times Cited: 46
Extracellular vesicle-mediated transport: Reprogramming a tumor microenvironment conducive with breast cancer progression and metastasis
Dara Brena, Ming‐Bo Huang, Vincent C. Bond
Translational Oncology (2021) Vol. 15, Iss. 1, pp. 101286-101286
Open Access | Times Cited: 39
Similarities and Differences of Hsp70, hsc70, Grp78 and Mortalin as Cancer Biomarkers and Drug Targets
Rajani Rai, Amy L. Kennedy, Zitha Redempta Isingizwe, et al.
Cells (2021) Vol. 10, Iss. 11, pp. 2996-2996
Open Access | Times Cited: 38
HSP70s in Breast Cancer: Promoters of Tumorigenesis and Potential Targets/Tools for Therapy
Alexander E. Kabakov, Vladimir L. Gabai
Cells (2021) Vol. 10, Iss. 12, pp. 3446-3446
Open Access | Times Cited: 37
Page 1 - Next Page

Scroll to top